ArticleCureus2025
False-Positive Elevation of Blood Gas Bilirubin in a Patient With Mixed Drug Overdose Involving Pregabalin and Diazepam Abuse.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bilirubin measurements are commonly performed using a blood gas analyzer and are particularly useful in managing neonatal hyperbilirubinemia. This report presents a case of a white British man in his 40s who was treated for a mixed drug overdose involving cocaine, mirtazapine, fentanyl, codeine, methadone, morphine, and diazepam. His bilirubin levels measured on the blood gas analyzer were elevated at 63 µmol/L, whereas the normal range is 1.71-20.5 µmol/L. However, a formal laboratory bilirubin test returned a normal value of 21 µmol/L. Given the absence of jaundice or signs of liver disease, the unexpectedly high bilirubin reading on the blood gas analyzer prompted further investigation. Laboratory analysis involved scanning the absorbance of three serum samples received on the same day and comparing them with the absorbance of the blood gas analyzer. A significant peak at approximately 400 nm was detected in the first sample, corresponding to the wavelengths used for blood gas bilirubin measurement. Native bilirubin exhibits a broad absorbance spectrum between 350 and 500 nm, overlapping with the absorbance spectra of diazepam and pregabalin. This interference likely contributed to the false-positive bilirubin elevation. Currently, little is known about the relationship between false-positive bilirubin elevations and drugs of abuse. This case highlights potential causes of isolated bilirubin elevation, particularly interference from substances with overlapping absorbance spectra. While the interference is suspected, it has not been definitively proven. The findings underscore the limitations of arterial blood gas analysis and the potential for interference from other substances, particularly drugs of abuse. Clinicians should exercise caution when interpreting blood gas bilirubin concentrations in patients with a history of substance misuse. Consulting the laboratory is advisable when encountering unexpected discrepancies in bilirubin levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.